Cargando…

Single-Cell Proteomic Profiling Identifies Nanoparticle Enhanced Therapy for Triple Negative Breast Cancer Stem Cells

Breast cancer remains a major cause of cancer-related deaths in women worldwide. Chemotherapy-promoted stemness and enhanced stem cell plasticity in breast cancer is a cause for great concern. The discovery of drugs targeting BCSCs was suggested to be an important advancement in the establishment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wenzheng, Lei, Bo, Li, Lin, Liu, Jianyu, Li, Zhihui, Pang, Yuheng, Liu, Tong, Li, Zhigao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616083/ https://www.ncbi.nlm.nih.gov/pubmed/34831064 http://dx.doi.org/10.3390/cells10112842

Ejemplares similares

Cancer stem cells promote lymph nodes metastasis of breast cancer by reprogramming tumor microenvironment
por: Li, Lin, et al.
Publicado: (2023)

Identification of Genes Associated with Prognosis and Immunotherapy Prediction in Triple-Negative Breast Cancer via M1/M2 Macrophage Ratio
por: Liu, Jianyu, et al.
Publicado: (2023)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

Depletion of Mdig Changes Proteomic Profiling in Triple Negative Breast Cancer Cells
por: Thakur, Chitra, et al.
Publicado: (2022)

Functional Proteomic Profiling of Triple-Negative Breast Cancer
por: Gromova, Irina, et al.
Publicado: (2021)

Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer
por: Liu, Mingshan, et al.
Publicado: (2018)

Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
por: Liu, Siyan, et al.
Publicado: (2022)

Targeting mitochondrial dynamics by AZD5363 in triple-negative breast cancer MDA-MB-231 cell–derived spheres
por: Fu, Yingqiang, et al.
Publicado: (2023)

Construction and Identification of New Molecular Markers of Triple-Negative Breast Cancer Stem Cells
por: Liu, Tingting, et al.
Publicado: (2021)

Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type
por: Rust, Steven, et al.
Publicado: (2013)

Chemical-proteomics Identify Peroxiredoxin-1 as an Actionable Target in Triple-negative Breast Cancer
por: Spínola-Lasso, Elena, et al.
Publicado: (2023)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner, Jessica, et al.
Publicado: (2015)

Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
por: Shi, Peiguo, et al.
Publicado: (2017)

Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer
por: Zhang, Xingda, et al.
Publicado: (2022)

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
por: Park, So-Yeon, et al.
Publicado: (2019)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells
por: Liu, Ying, et al.
Publicado: (2016)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2015)

Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem Cells
por: Yi, Huimei, et al.
Publicado: (2020)

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
por: Wang, Yuyi, et al.
Publicado: (2018)

Thioridazine combined with carboplatin results in synergistic inhibition of triple negative breast cancer by targeting cancer stem cells
por: Wang, Yi, et al.
Publicado: (2022)

Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment
por: Li, Yuan, et al.
Publicado: (2022)

Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4
por: Chen, Fei, et al.
Publicado: (2020)

Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer
por: Sun, Huizhi, et al.
Publicado: (2019)

Chemotherapeutic Stress Influences Epithelial–Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer
por: Li, Xiao, et al.
Publicado: (2020)

Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer
por: Dogra, Prashant, et al.
Publicado: (2022)

HES1 promotes breast cancer stem cells by elevating Slug in triple-negative breast cancer
por: Li, Xiaoying, et al.
Publicado: (2021)

LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2020)

KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023)

Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells
por: Li, Xinyang, et al.
Publicado: (2022)

Proteomic characterisation of triple negative breast cancer cells following CDK4/6 inhibition
por: Beykou, Melina, et al.
Publicado: (2022)

Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer
por: Chen, Sisi, et al.
Publicado: (2022)

Proteomic Landscape of Exosomes Reveals the Functional Contributions of CD151 in Triple-Negative Breast Cancer
por: Li, Sipeng, et al.
Publicado: (2021)

Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
por: Liu, Jianyu, et al.
Publicado: (2021)

Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells
por: Xue, Lian, et al.
Publicado: (2022)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
por: Tzeng, Yen-Dun Tony, et al.
Publicado: (2018)

Recent advances in targeted strategies for triple-negative breast cancer
por: Zhu, Shuangli, et al.
Publicado: (2023)

Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity
por: Li, Ying-Wei, et al.
Publicado: (2018)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

Network Pharmacology–Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells
por: Zhang, Yu-Zhu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ek51ufu3p13ibbusr73ghtok7f